Idiopathic pulmonary fibrosis – Diagnostics – Overview of Information and Clinical Research

Diagnosing idiopathic pulmonary fibrosis can be a complex process that involves multiple tests and careful examination to understand what is happening in the lungs. Because the disease causes scarring in the lungs without a clear reason, doctors need to rule out other possible causes and gather detailed information before confirming the diagnosis.

Introduction: Who Should Seek Diagnostic Testing

If you have been experiencing shortness of breath that has lasted for a while or have had a persistent cough for more than three weeks, it is important to see a doctor. These symptoms are not normal and should not be dismissed as simply getting older or being out of shape. Many people with idiopathic pulmonary fibrosis initially ignore their breathlessness and attribute it to age or lack of fitness, but early medical attention can make a significant difference.^[1]^[4]

People who are at higher risk for developing this condition should be especially watchful. If you smoke, have a family history of pulmonary fibrosis, are over the age of 65, or have been exposed to certain dusts or chemicals through your work, you should pay close attention to any breathing difficulties or chronic cough. The disease usually affects people who are around 70 to 75 years old and is rare in those under 50. It is more common in men than in women.^[1]^[4]^[8]

Early symptoms of idiopathic pulmonary fibrosis can be subtle. You might notice that you become short of breath during activities that never used to tire you, such as climbing stairs or walking short distances. As the disease progresses, even light activities like getting dressed can cause breathlessness. Other signs include extreme tiredness, unexplained weight loss, aching muscles and joints, and changes in the fingertips, which may become widened and rounded in a condition known as clubbing.^[3]^[4]

Classic Diagnostic Methods

When you visit your doctor with concerns about persistent breathing problems or cough, the diagnostic journey begins with a thorough review of your medical and family history. Your doctor will ask detailed questions about your symptoms, how long they have been present, and whether you have been exposed to substances like asbestos, silica, metal dust, wood dust, or agricultural materials. They will also want to know about any medications you are taking, as some drugs can cause lung scarring.^[4]^[6]^[11]

During a physical examination, your healthcare professional will listen carefully to your lungs with a stethoscope while you breathe. A characteristic sign of pulmonary fibrosis is a crackling sound, often described as similar to the sound of velcro being pulled apart, which can be heard at the base of the lungs. This sound occurs because of the stiff, scarred tissue in the lungs.^[6]

After the initial exam, your doctor may refer you to a hospital specialist for more detailed testing. This specialist is often a pulmonologist, a doctor who focuses on lung diseases. The specialist will use a combination of imaging studies, breathing tests, and sometimes tissue samples to confirm the diagnosis and rule out other conditions that can cause similar symptoms.^[4]

Imaging Tests

A chest X-ray is often one of the first imaging tests ordered. This simple test can reveal the scar tissue that is typical of pulmonary fibrosis. However, in some cases, especially in the early stages of the disease, a chest X-ray may appear normal even when lung damage is present. When this happens, more advanced imaging is needed.^[11]

High-resolution computed tomography, or HRCT scan, is a crucial diagnostic tool for idiopathic pulmonary fibrosis. This type of CT scan creates detailed, three-dimensional images of your lungs by combining multiple X-ray pictures taken from different angles. The HRCT can show the pattern and extent of scarring in the lung tissue with much greater clarity than a standard chest X-ray. Certain patterns seen on an HRCT scan are very characteristic of idiopathic pulmonary fibrosis, which helps doctors distinguish it from other types of lung disease.^[2]^[6]^[11]

Doctors may also use an echocardiogram, which is an ultrasound test of the heart. This test uses sound waves to create moving pictures of your heart and shows how well it is working. It is particularly helpful for detecting pulmonary hypertension, which is high blood pressure in the arteries of the lungs. This complication can occur as a result of idiopathic pulmonary fibrosis because the scarred lung tissue makes it harder for blood to flow through the lungs, forcing the heart to work harder.^[11]

Lung Function Tests

Pulmonary function tests, also called breathing tests or lung function tests, are essential for understanding how well your lungs are working. These tests measure how much air your lungs can hold and how quickly you can move air in and out of your lungs. They also measure how efficiently your lungs transfer oxygen into your bloodstream.^[4]^[6]^[11]

Spirometry is one of the most common lung function tests. During this test, you breathe out quickly and forcefully through a tube connected to a machine. The machine measures the total volume of air you can exhale and how fast you can do it. In people with pulmonary fibrosis, the lungs become stiff and cannot expand properly, so the amount of air they can hold is reduced.^[11]

Another important test measures how well oxygen moves from your lungs into your blood. This test, called a diffusion capacity test, shows whether the scarring in your lungs is interfering with oxygen transfer. When lung tissue is damaged and scarred, it becomes much harder for oxygen to pass from the air sacs into the tiny blood vessels surrounding them.^[11]

⚠️ Important

Lung function tests are also used to monitor how the disease is progressing over time. Your doctor will likely repeat these tests at regular intervals to see if your lung capacity is staying stable or declining. A drop in lung capacity of 10% or more within a year is considered significant and may lead to changes in your treatment plan.

Blood Tests

Blood tests play an important role in the diagnostic process, although they cannot directly diagnose idiopathic pulmonary fibrosis. Doctors use blood tests to rule out other conditions that can cause lung scarring, such as autoimmune diseases like rheumatoid arthritis, lupus, or scleroderma. These diseases can cause inflammation and scarring in the lungs, but they have different treatments than idiopathic pulmonary fibrosis.^[4]^[11]

An arterial blood gas test measures the levels of oxygen and carbon dioxide in your blood. This test helps doctors understand how well your lungs are delivering oxygen to your bloodstream and removing carbon dioxide. In people with pulmonary fibrosis, oxygen levels may be lower than normal, especially during physical activity.^[11]

Lung Biopsy

In some cases, when the diagnosis is not clear from imaging and other tests, your doctor may recommend a lung biopsy. This procedure involves taking a small sample of lung tissue so it can be examined under a microscope. The biopsy helps doctors see the pattern of scarring and rule out other lung diseases.^[4]^[11]

A lung biopsy can be done in different ways. One method is through bronchoscopy, where a thin, flexible tube with a camera is passed through your nose or mouth, down your windpipe, and into your lungs. Small tissue samples can be taken through this tube. Another method is a surgical biopsy, often done using keyhole surgery, where small incisions are made in the chest wall and instruments are inserted to remove tissue samples. The type of biopsy your doctor recommends will depend on your individual situation and what information is needed to make a confident diagnosis.^[4]^[11]

Diagnostics for Clinical Trial Qualification

When patients with idiopathic pulmonary fibrosis are being considered for participation in clinical trials, they typically need to undergo a standard set of diagnostic tests. These tests help researchers ensure that participants meet specific criteria and that the study results will be meaningful. The tests also provide baseline measurements that can be compared to results during and after the trial to see if the experimental treatment is working.

High-resolution CT scans are commonly required as part of the screening process for clinical trials. Researchers need to see detailed images of the lung scarring to confirm the diagnosis and assess how advanced the disease is. The pattern of scarring seen on the scan must match what is expected in idiopathic pulmonary fibrosis. If the scan shows a pattern more consistent with another type of lung disease, the person may not qualify for the trial.^[2]

Pulmonary function tests are another standard requirement for clinical trial enrollment. Most trials specify that participants must have a certain level of lung function, often measured by forced vital capacity, or FVC. This measurement shows how much air you can forcefully exhale after taking the deepest breath possible. Many trials require that lung capacity be between 50% and 80% of what would be expected for a healthy person of the same age, height, and sex. This requirement helps ensure that participants are at a stage of disease where they might benefit from the treatment being studied.^[10]^[22]

Blood tests may be performed to check liver and kidney function before enrollment in a clinical trial. This is especially important when the trial involves testing medications, as some drugs can affect these organs. If a person’s liver or kidney function is not within acceptable ranges, they may not be able to safely participate.^[10]

Some clinical trials may also require an assessment of oxygen levels in the blood, both at rest and during exercise. This can be done with a simple device called a pulse oximeter that clips onto your finger, or through an arterial blood gas test. Understanding how well your lungs are delivering oxygen helps researchers determine if you are at the right stage of disease for the particular treatment being studied.

Additional tests may be needed depending on the specific focus of the clinical trial. For example, if the trial is testing a treatment that might affect the heart, an echocardiogram or electrocardiogram may be required. If the treatment could potentially affect the immune system, more detailed blood tests to assess immune function might be necessary. The specific diagnostic requirements vary from one trial to another and will be clearly explained when you are being considered for participation.^[4]

Prognosis and Survival Rate

Prognosis

The outlook for people with idiopathic pulmonary fibrosis varies significantly from person to person, and it is very difficult to predict at the time of diagnosis how the disease will progress in any individual. In some people, the disease stays relatively stable for many years, with symptoms remaining manageable and lung function declining slowly. In others, the condition worsens more quickly, with rapid loss of lung capacity and increasing breathlessness. Regular monitoring over time helps doctors understand whether the disease is progressing quickly or slowly in a particular patient.^[4]^[7]

The way idiopathic pulmonary fibrosis progresses is unpredictable. Some patients may experience what are called acute exacerbations, which are sudden episodes where symptoms become much worse over a period of days or weeks. These events can be life-threatening and are more common in advanced stages of the disease. Sometimes these episodes are triggered by infections or other factors, but often there is no obvious cause. People who have one acute exacerbation are at risk of having more in the future.^[1]^[19]

Several factors can affect how the disease progresses. Age plays a role, as does overall health and the presence of other medical conditions. Whether a person smokes also impacts prognosis, and quitting smoking is one of the most important things someone with idiopathic pulmonary fibrosis can do. The extent of lung scarring seen on CT scans and the results of lung function tests at diagnosis also provide some information about likely progression, though they cannot predict with certainty what will happen for any individual.^[1]^[6]

Complications that can develop as the disease progresses include respiratory failure, which happens when the lungs cannot deliver enough oxygen to the body without support. Pulmonary hypertension, or high blood pressure in the arteries of the lungs, can also occur and puts additional strain on the heart, potentially leading to heart failure. People with idiopathic pulmonary fibrosis are also at higher risk for lung infections, blood clots in the lungs, and lung cancer.^[1]^[4]^[8]^[19]

Survival rate

The average life expectancy following a diagnosis of idiopathic pulmonary fibrosis is approximately three to five years, though this estimate comes from older research conducted before newer treatments became widely available. It is important to understand that this is an average, and individual outcomes can vary widely. Some people live much longer than this average, particularly if their disease progresses slowly or if they are able to receive a lung transplant.^[7]^[8]^[13]

Recent advances in treatment have improved the outlook for people with idiopathic pulmonary fibrosis. Two medications, pirfenidone and nintedanib, have been shown to slow the decline in lung function and may extend survival, though they cannot stop or reverse the scarring. Lung transplantation is the only treatment that has been proven to increase life expectancy significantly, but this option is only suitable for a small number of patients who meet specific criteria.^[8]^[10]^[13]

Your healthcare team will monitor your condition regularly to assess how the disease is progressing and to watch for any complications. These regular checkups help ensure that you receive appropriate treatment adjustments as needed and that any new problems are identified and addressed quickly. Although idiopathic pulmonary fibrosis is a serious condition, many people are able to maintain quality of life for a significant period with proper management and support.^[4]^[19]